genetic screening

Oncology

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

News

With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.